Nuvation Bio

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$1,435
$264
$264
$0
Gross Profit
-156
-58
209
-55
EBITDA
-45,071
-20,141
-20,776
-26,679
EBIT
-45,315
-20,199
-20,819
-26,734
Net Income
-462,492
-14,792
-13,787
-19,649
Net Change In Cash
1,435
264
264
0
Free Cash Flow
-37,324
-15,729
-15,042
-16,177
Cash
34,285
34,510
42,649
24,395
Basic Shares
244,738
219,048
218,993
218,935

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-222
-484
-368
-103
EBITDA
-99,600
-128,693
-97,285
-43,666
EBIT
-99,822
-129,177
-97,653
-43,769
Net Income
-75,802
-88,664
-79,734
-39,496
Net Change In Cash
0
0
0
0
Cost of Revenue
-31,324
102,668
Free Cash Flow
-68,068
-96,478
-68,472
-36,674
Cash
42,649
101,099
132,423
29,755
Basic Shares
218,880
216,721
197,887
97,530

Earnings Calls

Quarter EPS
2024-06-30
-$0.15
2024-03-31
-$0.07
2023-12-31
-$0.06
2023-09-30
-$0.09